BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24711698)

  • 1. Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide.
    Messaoudi K; Saulnier P; Boesen K; Benoit JP; Lagarce F
    Int J Nanomedicine; 2014; 9():1479-90. PubMed ID: 24711698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.
    Danhier F; Messaoudi K; Lemaire L; Benoit JP; Lagarce F
    Int J Pharm; 2015 Mar; 481(1-2):154-61. PubMed ID: 25644286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
    Resnier P; David S; Lautram N; Delcroix GJ; Clavreul A; Benoit JP; Passirani C
    Int J Pharm; 2013 Oct; 454(2):748-55. PubMed ID: 23583841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.
    Fernandes JC; Qiu X; Winnik FM; Benderdour M; Zhang X; Dai K; Shi Q
    Int J Nanomedicine; 2012; 7():5833-45. PubMed ID: 23209368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration.
    David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C
    Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
    Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C
    Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP; Godoy PR; Sakamoto-Hojo ET
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
    Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
    J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.
    Cominelli M; Grisanti S; Mazzoleni S; Branca C; Buttolo L; Furlan D; Liserre B; Bonetti MF; Medicina D; Pellegrini V; Buglione M; Liserre R; Pellegatta S; Finocchiaro G; Dalerba P; Facchetti F; Pizzi M; Galli R; Poliani PL
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25739547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.
    Nitta Y; Shimizu S; Shishido-Hara Y; Suzuki K; Shiokawa Y; Nagane M
    Cancer Med; 2016 Mar; 5(3):486-99. PubMed ID: 26778701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
    Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
    Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
    Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
    J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells.
    Munoz JL; Rodriguez-Cruz V; Greco SJ; Nagula V; Scotto KW; Rameshwar P
    Mol Cancer Ther; 2014 Oct; 13(10):2399-411. PubMed ID: 25053824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.
    Johannessen TC; Prestegarden L; Grudic A; Hegi ME; Tysnes BB; Bjerkvig R
    Neuro Oncol; 2013 Mar; 15(3):269-78. PubMed ID: 23258843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide.
    Zhang L; Wang H
    Pharmacol Rep; 2017 Dec; 69(6):1186-1193. PubMed ID: 29128799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and comparison of two novel nanosystems associated with siRNA for cellular therapy.
    André EM; Pensado A; Resnier P; Braz L; Rosa da Costa AM; Passirani C; Sanchez A; Montero-Menei CN
    Int J Pharm; 2016 Jan; 497(1-2):255-67. PubMed ID: 26617318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
    Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
    J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
    Gokturk D; Kelebek H; Ceylan S; Yilmaz DM
    Turk Neurosurg; 2018; 28(1):13-18. PubMed ID: 28191621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomic analysis and functional studies reveal that nucleophosmin is involved in cell death in glioblastoma cell line transfected with siRNA.
    Gimenez M; Marie SK; Oba-Shinjo SM; Uno M; da Silva R; Laure HJ; Izumi C; Otake A; Chammas R; Rosa JC
    Proteomics; 2012 Aug; 12(17):2632-40. PubMed ID: 22745010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
    Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
    ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.